Back to calendar
AgomAb Therapeutics NV (AGMB) Earnings
AGMB reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.45
Actual EPS: $-0.45
EPS surprise: -16.18%
Company overview
Market Cap$706.7M
PriceUSD 14.50
52-week high17.82
52-week low8.75
SectorHealth Technology
IndustryBiotechnology
Employees62